NANNETTI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1.786
EU - Europa 311
AS - Asia 238
SA - Sud America 7
AF - Africa 1
Totale 2.343
Nazione #
US - Stati Uniti d'America 1.784
IT - Italia 147
CN - Cina 130
SG - Singapore 83
DE - Germania 32
FI - Finlandia 32
SE - Svezia 22
RU - Federazione Russa 20
GB - Regno Unito 16
FR - Francia 15
IN - India 10
IE - Irlanda 7
VN - Vietnam 6
BR - Brasile 5
UA - Ucraina 5
NL - Olanda 4
KR - Corea 3
CA - Canada 2
ES - Italia 2
HK - Hong Kong 2
LU - Lussemburgo 2
PT - Portogallo 2
AT - Austria 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
ID - Indonesia 1
IL - Israele 1
LI - Liechtenstein 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
Totale 2.343
Città #
Fairfield 320
Woodbridge 155
Ann Arbor 151
Ashburn 151
Houston 150
Chandler 140
Seattle 120
Cambridge 113
Wilmington 101
Singapore 64
Santa Clara 54
Boardman 36
San Diego 29
Padova 25
Helsinki 23
Beijing 21
Medford 18
Princeton 18
Des Moines 16
Roxbury 13
Columbus 12
Guangzhou 11
Nanjing 9
Pune 9
Shanghai 9
Dearborn 8
Dublin 7
Rome 7
Cagliari 6
Frankfurt am Main 6
Perugia 6
Dong Ket 5
Kharkiv 5
Milan 5
Vicenza 4
Cardiff 3
Florence 3
Hebei 3
Hefei 3
Kunming 3
Ludwigsburg 3
Nanchang 3
Nürnberg 3
Shenyang 3
Siena 3
Turin 3
Brescia 2
Edinburgh 2
Kilburn 2
London 2
Luxembourg 2
Mantova 2
Naples 2
New York 2
Parma 2
Salerno 2
São Paulo 2
Taiyuan 2
Taizhou 2
Venice 2
Verona 2
Zhengzhou 2
Abano Terme 1
Aprilia 1
Aracaju 1
Arapiraca 1
Berlin 1
Bologna 1
Borås 1
Boston 1
Bucharest 1
Buffalo 1
Cavallino 1
Changsha 1
Chengdu 1
Chiswick 1
Cochabamba 1
Copenhagen 1
Dallas 1
Desio 1
Figline Valdarno 1
Fossò 1
Gunzenhausen 1
Hangzhou 1
Hanoi 1
Hong Kong 1
Islington 1
Jakarta 1
Jiaxing 1
Jinan 1
Langfang 1
Las Vegas 1
Lisbon 1
Luoyang 1
Madrid 1
Manchester 1
Matozinhos 1
Miami 1
Miami Beach 1
Moscow 1
Totale 1.930
Nome #
4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling 203
A Broad anti-influenza hybrid small molecule that potently disrupts the interaction of polymerase acidic protein-basic protein 1 (PA-PB1) subunits 168
Antiviral strategies against influenza virus: towards new therapeutic approaches. 164
Sviluppo e caratterizzazione di nuovi inibitori diretti contro la polimerasi dei virus dell'influenza di tipo A e B 161
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 155
Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication 151
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 140
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 136
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 133
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 131
Optimization of Small-Molecule Inhibitors of Influenza Virus Polymerase: From Thiophene-3-Carboxamide to Polyamido Scaffolds 130
Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly. 127
A sensitive and validated HPLC-UV method for the quantitative determination of the new antifungal drug isavuconazole in human plasma 118
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 117
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 117
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 90
Corrigendum to “Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity” [Eur. J. Med. Chem. 138 (2017) 128–139] (S0223523417304610) (10.1016/j.ejmech.2017.06.015)) 88
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 73
Totale 2.402
Categoria #
all - tutte 8.460
article - articoli 7.901
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020229 0 0 0 0 0 0 0 65 81 35 37 11
2020/2021292 25 18 12 17 7 15 11 25 50 10 56 46
2021/2022332 8 58 28 29 41 21 18 34 9 11 16 59
2022/2023328 47 41 5 38 63 31 4 33 30 5 25 6
2023/2024234 3 32 26 13 30 22 41 16 3 20 16 12
2024/2025284 4 63 46 37 80 21 27 6 0 0 0 0
Totale 2.402